Transforming Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases

Orca Bio is dedicated to developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Orca Bio announces oral presentation of Orca-T Clinical Data at ASH 2020. Click here to learn more.